What antibiotics are used to treat different types of infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotics for Different Types of Infections

The most appropriate antibiotic treatment varies by infection type, with first-line options including amoxicillin-clavulanic acid for mild to moderate intra-abdominal infections, cephalosporins with metronidazole for severe intra-abdominal infections, and targeted therapy based on the specific pathogen and site of infection for skin/soft tissue infections. 1

Respiratory Tract Infections

  • For upper respiratory tract infections (URTI), antibiotics are generally not indicated as most cases are viral in origin 1
  • For lower respiratory tract infections (LRTI) in children under 3 years with pneumonia, amoxicillin (80-100 mg/kg/day) is the first-line treatment due to Streptococcus pneumoniae being the most common bacterial pathogen 1
  • For children over 3 years with pneumonia, treatment should be guided by clinical presentation - amoxicillin for suspected pneumococcal infection or macrolides if Mycoplasma pneumoniae or Chlamydia pneumoniae are suspected 1
  • For community-acquired pneumonia in adults, a 5-day course of antibiotics covering common pathogens is recommended, with options including amoxicillin, doxycycline, or a macrolide 2

Intra-abdominal Infections

  • For mild to moderate intra-abdominal infections, first-choice antibiotics include:

    • Amoxicillin-clavulanic acid 1
    • Ampicillin plus gentamicin plus metronidazole (particularly in children) 1
  • For severe intra-abdominal infections, first-choice antibiotics include:

    • Cefotaxime or ceftriaxone plus metronidazole 1
    • Piperacillin-tazobactam 1
    • Meropenem (as a second choice) 1
  • For surgery involving the intestinal or genitourinary tract, recommended options include:

    • Single-drug regimens: piperacillin-tazobactam, ticarcillin-clavulanate, carbapenems (imipenem, meropenem, ertapenem) 1
    • Combination regimens: ceftriaxone plus metronidazole, or fluoroquinolones (ciprofloxacin, levofloxacin) plus metronidazole 1

Skin and Soft Tissue Infections

  • For nonpurulent cellulitis, a 5-6 day course of antibiotics active against streptococci is recommended 1
  • For surgery of trunk or extremity away from axilla or perineum, options include:
    • Oxacillin/nafcillin, cefazolin (IV) or cephalexin (oral), sulfamethoxazole-trimethoprim, or vancomycin 1
  • For surgery of axilla or perineum, metronidazole plus either ciprofloxacin, levofloxacin, or ceftriaxone is recommended 1
  • For necrotizing infections, broad-spectrum coverage is necessary:
    • Vancomycin or linezolid plus piperacillin-tazobactam or a carbapenem; or plus ceftriaxone and metronidazole 1
    • For documented group A streptococcal necrotizing fasciitis, penicillin plus clindamycin is recommended 1

Urinary Tract Infections

  • For lower urinary tract infections, first-choice antibiotics include:

    • Amoxicillin-clavulanic acid 1
    • Sulfamethoxazole-trimethoprim 1
    • Nitrofurantoin (as a second choice) 1
  • For mild to moderate pyelonephritis and prostatitis:

    • Ciprofloxacin (first choice) 1
    • Ceftriaxone or cefotaxime (second choice) 1
  • For severe pyelonephritis and prostatitis:

    • Ceftriaxone or cefotaxime (first choice) 1
    • Amikacin (second choice) 1

Special Populations: Neutropenic Patients

  • For initial infections in neutropenic patients (first 7 days):

    • Broad-spectrum monotherapy with carbapenems, antipseudomonal cephalosporins, or piperacillin-tazobactam 1
    • Combination therapy using an aminoglycoside plus an antipseudomonal penicillin or extended-spectrum cephalosporin 1
  • For subsequent infections in neutropenic patients (after 7 days):

    • Pathogen-specific therapy based on culture results 1
    • Consider adding coverage for resistant gram-positive organisms (vancomycin, linezolid, or daptomycin) if clinically indicated 1

Important Clinical Considerations

  • Local resistance patterns should significantly influence antibiotic selection for empiric therapy 2
  • Shorter courses (5-7 days) are now recommended for many common infections, with extension based on clinical response rather than defaulting to longer courses 1
  • For many infections, narrow-spectrum antibiotics should be preferred when the causative pathogen is known to reduce the development of antimicrobial resistance 3
  • Amoxicillin-clavulanic acid is particularly useful for treating infections caused by beta-lactamase-producing organisms, including respiratory tract infections, skin infections, and urinary tract infections 4, 5

Common Pitfalls and Caveats

  • Inappropriate initial empirical antibiotic therapy is associated with increased mortality, particularly in nosocomial infections 1
  • Prior antibiotic exposure is a significant risk factor for receiving inadequate antimicrobial therapy 1
  • Vancomycin should not be used empirically for all infections but reserved for situations where MRSA is suspected or confirmed 1
  • When using doxycycline or other antibiotics, they should only be used to treat infections proven or strongly suspected to be caused by susceptible bacteria to reduce the development of drug-resistant bacteria 3
  • The emergence of resistant S. pneumoniae strains with elevated penicillin MICs in certain geographical areas may necessitate higher doses of amoxicillin-clavulanic acid 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.